Research Insights

Evidence-based analysis that brings peptide science to life. We synthesize clinical trials, identify trends, and tell you what the research actually shows — no hype, no hand-waving.

Trend ReportFeatured

GLP-1 Agonists Beyond Weight Loss

What 100+ clinical trials reveal about semaglutide, tirzepatide, and the next generation of incretin therapies — from cardiovascular protection to neurodegeneration.

8 min read5 peptides covered6 citations

Read analysis

Trend Report

The Mitochondrial Peptide Revolution

MOTS-c, SS-31, and Humanin are rewriting our understanding of aging at the cellular level. Here's what the research actually shows.

7 min14 citations

Research Digest

BPC-157 and Gut Healing: What 30+ Studies Actually Show

The most-cited peptide in the Atlas has a mountain of preclinical data. We break down what's proven, what's promising, and what's still missing.

6 min4 citations

Trend Report

Neuropeptides in 2026: Where the Research Actually Stands

Semax, Selank, Cerebrolysin, and Dihexa — separating clinical evidence from online hype in the cognitive enhancement space.

7 min13 citations

Research Digest

Tesamorelin: From HIV Lipodystrophy to Liver Health and Cognitive Enhancement

How a growth hormone-releasing peptide with 20+ RCTs became one of the most evidence-backed peptides in clinical medicine.

6 min6 citations

Research Digest

Thymic Peptides and Immune Restoration

Thymosin Alpha-1, Thymalin, and Thymulin — how thymus-derived peptides are being studied to combat immunosenescence and age-related immune decline.

6 min12 citations

Evidence Brief

The Evidence Gap: Which Popular Peptides Have Almost No Human Data?

A frank look at the disconnect between online popularity and clinical evidence for some of the most discussed peptides.

5 min12 citations

Research Digest

MK-677: The Oral Growth Hormone Secretagogue With 15 RCTs

One of the most studied non-injectable peptide mimetics — what the clinical trial evidence shows about sleep, muscle, bone, and the IGF-1 axis.

5 min5 citations

Evidence Brief

LL-37 and the Antimicrobial Peptide Frontier

As antibiotic resistance grows, host defense peptides like LL-37 are being studied as a fundamentally different approach to fighting infection.

5 min14 citations